Karolinska Institutet Science Park DAY
Welcome to Karolinska Institutet Science Park DAY Stockholm 2012
For the 3rd year running Karolinska Institutet Science Park is hosting this conference to present novel innovations. Also this year we have partnered with Globe Forum which will offer the possibility to meet prospective collaborators and enhance the chance of finding breakthrough solutions that will drive future business growth. Interested investors will have the opportunity to establish a first contact with presenting companies during a face to face networking session.
April 26, 2012 at Grand Hôtel, Stockholm
Presenting companies/projects: Akinion Pharmaceuticals AB, Axcentua Pharmaceuticals AB, Clanotech AB, Dilaforette AB, FISS, Glucox Biotech AB, Liquid Biopsy AB, Pergamum AB, SensAbues AB and SEPTEC.
Preliminary Programme
Moderator: Ingrid Stenberg, Biotech Sweden
| Time |
Topic |
| 08:00 - 09:00 |
Registration |
| 09:00 - 09:30 |
Opening - main
stage |
| 09:30 - 10:30 |
Life Science Programme - main
stage |
| 10:30 - 10:50 |
Coffee |
| 10:50 - 11:00 |
Opening KI Science Park DAY
Märit Johansson, Karolinska Institutet Science Park AB
Ingrid Stenberg, Biotech Sweden AB
|
| 11:00 - 12:00 |
Session 1: Company Presentations
AKN-028, a new oral kinase inhibitor in
early clinical development for Acute Myeloid
Leukemia
Carl Harald Janson, Akinion
Pharmaceuticals AB
Novel treatment of severe malaria
Pirkko Sulila Tamsen, Dilaforette
AB
A novel antibacterial treatment with a new
class of antimicrobial peptides
Mona Wilcke, The SEPTEC project
Finding specific Nox-inhibitors is the key
to new drugs
Per Wikström, Glucox
Biotech AB
CLT-28643 – A novel treatment for eye
diseases
Patrizia Caldirola, Clanotech
AB
|
| 12:00 - 13:30 |
Lunch |
| 13:30 - 14:20 |
Session 2: Company Presentations
Monitoring cancer cell spread by a simple blood test
Christer Ericsson, Liquid
Biopsy AB
Antimicrobial peptides with global
potential
Ulrika Wennberg, Pergamum
AB
Breath air drug testing
Bo Hammarlund,
SensAbues AB
Accelerated drug development through crystal re-engineering; the case of AXP107-11
Stefan Rehnmark, Axcentua
Pharmaceuticals AB
FISS-Radiosurgery
Elfar Úlfarsson, The
FISS project
|
| 14:20 - 14:30 |
Closing KI Science Park DAY
Ingrid Stenberg, Biotech Sweden AB
|
| 14:30 - 15:15 |
Coffee & face to face networking
session
Interested investors will have the opportunity
to establish a first contact with presenting
companies/projects.
|
